Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement
- PMID: 32461815
 - PMCID: PMC7244169
 - DOI: 10.19102/icrm.2020.110504
 
Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement
Abstract
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is the latest option among devices clinically available for the prevention of sudden cardiac death, with experience from previous trials and postmarketing studies supporting the feasibility and safety of this kind of system. The extracardiac positioning of the S-ICD obviates the need for transvenous leads, which translates into lower incidence rates of lead-related complications and systemic infections. This review will highlight the results of pertinent studies related to the perioperative management of S-ICDs and review potential approaches to minimizing the risk of complications such as hematoma at the pulse generator location, unsuccessful defibrillation due to suboptimal S-ICD lead and generator positioning, and postoperative pain. An extensive literature search using PubMed was conducted to identify relevant articles.
Keywords: Complications; periprocedural; subcutaneous implantable cardioverter-defibrillator.
Copyright: © 2020 Innovations in Cardiac Rhythm Management.
Conflict of interest statement
The authors report no conflicts of interest for the published content.
Figures
              
              
              
              
                
                
                
              
              
              
              
                
                
                
              
              
              
              
                
                
                
              
              
              
              
                
                
                References
- 
    
- Pfenniger A, Knight BP. Evolution of extravascular implantable defibrillator technologies. Prog Cardiovasc Dis. 2019;62(3):249–255. [CrossRef] [PubMed] - DOI - PubMed
 
 - 
    
- Santini M, Cappato R, Andresen D, et al. Current state of knowledge and experts’ perspective on the subcutaneous implantable cardioverter-defibrillator. J Interv Card Electrophysiol. 2009;25(1):83–88. [CrossRef] [PubMed] - DOI - PubMed
 
 - 
    
- Burke MC, Gold MR, Knight BP, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol. 2015;65(16):1605–1615. [CrossRef] [PubMed] - DOI - PubMed
 
 
LinkOut - more resources
Full Text Sources